This summary outlines recent health-related developments, including expansions in the bird flu vaccine supply, regulatory ...

The 2018-2019 influenza season is one such case. The vaccine’s effectiveness during that year was an abysmal 29%, according ...

Federal officials plan to double the stockpile of emergency bird flu vaccines as they identify more people infected with the ...

The companies will use the funds to fill vials and pre-filled syringes with stockpiled vaccine ingredients, aimed at raising ...

As more farm workers get sick with avian influenza, the US federal government is putting $72 million toward strengthening its ...

The Center for Biomedical Advanced Research and Development Authority (BARDA) is giving $72 million to three drugmakers to ...

The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi SA (NASDAQ:SNY) and ...

CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the ...

Sanofi (SNY), and CSL (CSLLY) win $72M U.S. contract to expand bird flu vaccine production amid fears of human transmission.

The U.S. government has allocated $72 million to GSK, Sanofi, and CSL Ltd to enhance bird flu vaccine production amid a ...

GSK, Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, ...